A Retrospective Comparison of Mortality in Critically Ill Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent-Reference-Cited by-同舟云学术

A Retrospective Comparison of Mortality in Critically Ill Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent

Published:2010-06 Issue:6 Volume:3 Page:578-585
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Exuzides Alex,Main Michael L.,Colby Chris,Grayburn Paul A.,Feinstein Steven B.,Goldman Jonathan H.

Funder

Lantheus Medical Imaging

General Electric Healthcare

Philips Ultrasound, Evalve, Inc.

National Institutes of Health

GE Healthcare

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference19 articles.

1. Thinking outside the “box”—the ultrasound contrast controversy;Main;J Am Coll Cardiol,2007

2. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration);Grayburn;Am J Cardiol,2008

3. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive patients;Kusnetzky;J Am Coll Cardiol,2008

4. Contrast echocardiography is superior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients;Kornbluth;Am Heart J,2000

5. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients;Reilly;J Am Coll Cardiol,2000

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of administrative claims to identify ultrasound enhancing agent use;Echo Research & Practice;2024-02-07

2. Ultrasound-Enhancing Agent Safely Enhances Left Ventricular Visualization by Transthoracic Echocardiography in Patients on ECMO Support;Journal of Cardiothoracic and Vascular Anesthesia;2024-01

3. Efficacy and safety of use of ultrasound enhancing agent in patients hospitalized with COVID-19;The International Journal of Cardiovascular Imaging;2023-12-14

4. Safety of Lumason® (SonoVue®) in special populations and critically ill patients;Frontiers in Cardiovascular Medicine;2023-08-02

5. Impact of ultrasound enhancing agents on clinical management;Current Opinion in Cardiology;2022-09